Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.
Bruyere O, Roux C, Detilleux J, Slosman DO, Spector TD, Fardellone P, Brixen K, Devogelaer JP, Diaz-Curiel M, Albanese C, Kaufman JM, Pors-Nielsen S, Reginster JY. Bruyere O, et al. Among authors: roux c. J Clin Endocrinol Metab. 2007 Aug;92(8):3076-81. doi: 10.1210/jc.2006-2758. Epub 2007 Jun 12. J Clin Endocrinol Metab. 2007. PMID: 17566094 Free article. Clinical Trial.
Intermittent cyclic tiludronate in the treatment of osteoporosis.
Reginster JY, Christiansen C, Roux C, Fechtenbaum J, Rouillon A, Tou KP. Reginster JY, et al. Among authors: roux c. Osteoporos Int. 2001;12(3):169-77. doi: 10.1007/s001980170126. Osteoporos Int. 2001. PMID: 11315234 Clinical Trial.
Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.
Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P, Cormier C, Isaia G, Badurski J, Wark JD, Collette J, Reginster JY. Meunier PJ, et al. Among authors: roux c. Osteoporos Int. 2009 Oct;20(10):1663-73. doi: 10.1007/s00198-008-0825-6. Epub 2009 Jan 20. Osteoporos Int. 2009. PMID: 19153678 Free PMC article. Clinical Trial.
Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis.
Delmas PD, Vrijens B, Eastell R, Roux C, Pols HA, Ringe JD, Grauer A, Cahall D, Watts NB; Improving Measurements of Persistence on Actonel Treatment (IMPACT) Investigators. Delmas PD, et al. Among authors: roux c. J Clin Endocrinol Metab. 2007 Apr;92(4):1296-304. doi: 10.1210/jc.2006-1526. Epub 2007 Jan 23. J Clin Endocrinol Metab. 2007. PMID: 17244788 Clinical Trial.
Design for an ipriflavone multicenter European fracture study.
Reginster JY, Bufalino L, Christiansen C, Devogelaer JP, Gennari C, Riis BJ, Roux C. Reginster JY, et al. Among authors: roux c. Calcif Tissue Int. 1997;61 Suppl 1:S28-32. doi: 10.1007/s002239900382. Calcif Tissue Int. 1997. PMID: 9263614 Clinical Trial.
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis.
Reginster JY, Kaufman JM, Goemaere S, Devogelaer JP, Benhamou CL, Felsenberg D, Diaz-Curiel M, Brandi ML, Badurski J, Wark J, Balogh A, Bruyère O, Roux C. Reginster JY, et al. Among authors: roux c. Osteoporos Int. 2012 Mar;23(3):1115-22. doi: 10.1007/s00198-011-1847-z. Epub 2011 Nov 29. Osteoporos Int. 2012. PMID: 22124575 Free PMC article. Clinical Trial.
2,126 results